Literature DB >> 971709

Measurement of plasma levels of tricylic psychoactive drugs and their metabolites by UV reflectance photometry of thin layer chromatograms.

U Breyer, K Villumsen.   

Abstract

A method has been developed for the determination of perazine, clozapine, imipramine and amitriptyline and their demethylated metabolites in plasma. Other metabolites measured were perazine sulfoxide and the N-oxides of clozapine and perazine, the latter two following their reduction to the parent drugs with ascorbic acid. 10-Hydroxynortriptyline was identified as an amitriptyline metabolite in plasma. The general procedure included extraction of alkalinized plasma samples (3 - 6 g) with benzene or toluene and thin layer chromatography of the extracts, followed by reflectance photometry of the plates at appropriate wave lengths in ultraviolet light. Spots of questionable identity were further characterized by two-dimensional chromatography and by colour reactions. Therecoveries of compounds added in therapeutic concentrations were between 70 and 98 %. The limits of detectability were 5 - 10 ng/g plasma.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 971709     DOI: 10.1007/BF00606565

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  25 in total

1.  Thin-layer chromatographic determination of barbiturates and phenytoin in serum and blood.

Authors:  U Breyer; D Villumsen
Journal:  J Chromatogr       Date:  1975-12-24

2.  Perphenazine concentrations in human whole blood. A pilot study during anti-psychotic therapy using different administration forms.

Authors:  C E Hansen; N E Larsen
Journal:  Psychopharmacologia       Date:  1974-06-18

3.  Antipsychotic efficacy of clozapine in correlation to changes in catecholamine metabolism in man.

Authors:  M Ackenheil; H Beckmann; W Greil; G Hoffmann; E Markianos; J Raese
Journal:  Adv Biochem Psychopharmacol       Date:  1974

4.  Quantitation of chlorpromazine and its metabolites by two-dimensional thin-layer chromatography and direct scanning microdensitometry.

Authors:  P Turano; W J Turner
Journal:  J Chromatogr       Date:  1972-02-02

5.  Accumulation and elimination of a novel metabolite during chronic administration of the phenothiazine drug perazine to rats.

Authors:  U Breyer
Journal:  Biochem Pharmacol       Date:  1972-05-15       Impact factor: 5.858

6.  A method for determination of chlorpromazine in human blood serum.

Authors:  G W Christoph; D E Schmidt; J M Davis; D S Janowsky
Journal:  Clin Chim Acta       Date:  1972-05       Impact factor: 3.786

7.  A fluorometric method for the measurement of butaperazine in human plasma.

Authors:  D H Manier; J Sekerke; J V Dingell; M K El-Yousef
Journal:  Clin Chim Acta       Date:  1974-12-17       Impact factor: 3.786

8.  Plasma levels of imipramine and desmethylimipramine during therapy.

Authors:  J P Moody; A C Tait; A Todrick
Journal:  Br J Psychiatry       Date:  1967-02       Impact factor: 9.319

9.  Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compounds.

Authors:  W Hammer; F Sjöqvist
Journal:  Life Sci       Date:  1967-09-01       Impact factor: 5.037

10.  Relationship between plasma level and therapeutic effect of nortriptyline.

Authors:  M Asberg; B Crönholm; F Sjöqvist; D Tuck
Journal:  Br Med J       Date:  1971-08-07
View more
  10 in total

Review 1.  Plasma level monitoring of tricyclic antidepressant therapy.

Authors:  L F Gram
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

2.  Determination of clozapine and its N-demethylated metabolite in plasma by use of gas chromatography-mass spectrometry with single ion detection.

Authors:  U Bondesson; L H Lindström
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  Binding of tricyclic antidepressants and perazine to human plasma. Methodology and findings in normals.

Authors:  M Brinkschulte; U Breyer-Pfaff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-07       Impact factor: 3.000

4.  Plasma protein binding of perazine and amitriptyline in psychiatric patients.

Authors:  M Brinkschulte; H J Gaertner; H W Schied; U Breyer-Pfaff
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients. Clinical aspects, psychophysiology, and drug plasma levels.

Authors:  H Giedke; H Gaertner; U Breyer-Pfaff; W Rein; D Axmann
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

6.  Pharmacokinetics of clozapine and its metabolites in psychiatric patients: plasma protein binding and renal clearance.

Authors:  G Schaber; I Stevens; H J Gaertner; K Dietz; U Breyer-Pfaff
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

Review 7.  Pharmacokinetics and pharmacodynamics of clozapine.

Authors:  M W Jann; S R Grimsley; E C Gray; W H Chang
Journal:  Clin Pharmacokinet       Date:  1993-02       Impact factor: 6.447

8.  Cyclobarbital as a test substance for oxidative drug metabolism in man. Findings in neuropsychiatric patients.

Authors:  U Breyer-Pfaff; H Jerg; F Petruch
Journal:  Eur J Clin Pharmacol       Date:  1979-07       Impact factor: 2.953

9.  A simplified radioimmunoassay of plasma nortriptyline in depressed patients compared with high-pressure liquid chromatography and gas-liquid chromatography.

Authors:  J F Sayegh
Journal:  Neurochem Res       Date:  1986-02       Impact factor: 3.996

10.  Antidepressive effect and pharmacokinetics of amitriptyline with consideration of unbound drug and 10-hydroxynortriptyline plasma levels.

Authors:  U Breyer-Pfaff; H J Gaertner; F Kreuter; G Scharek; M Brinkschulte; R Wiatr
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.